Entecavir Monohydrate CAS 209216-23-9 API Factory High Quality Antiviral Hepatitis B Infection
Phepelo ea Moetsi e nang le Bohloeki bo Phahameng le Boleng bo tsitsitseng
Lebitso la lik'hemik'hale: Entecavir Monohydrate
CAS: 209216-23-9
E sebelisoa ho phekola lefu la Hepatitis B
API Boleng bo Phahameng, Tlhahiso ea Khoebo
Lebitso la Lik'hemik'hale | Entecavir Monohydrate |
Litlhaloso tse tšoanang | Entecavir Hydrate;9 - [(1S,3R,4S) -4-Hydroxy-3-(hydroxymethyl) -2-methylenecyclopentyl]guanine Monohydrate |
Nomoro ea CAS | 209216-23-9 |
Nomoro ea KAtse | RF-API79 |
Boemo ba Setoko | Ka Setokong, Phatlalatso e Eketsehile ho fihla ho Makholo a Lik'hilograma |
Foromo ea limolek'hule | C12H17N5O4 |
Boima ba Molek'hule | 295.3 |
Melting Point | >220℃ |
Botenya | 1.81 |
Boemo ba ho Romela | E Rometsoe ka Tlas'a Mocheso oa Mocheso |
Brand | Ruifu Chemical |
Ntho | Litlhaloso |
Ponahalo | Phofo ea Crystalline e tšoeu kapa e batlang e le tšoeu |
Solubility | E qhibiliha ka bolokolohi ho Dimethylformamide, e Hanyenyane Hanyenyane ka Metsing, Ethanol le Methanol |
Boitsebiso ba IR | Spectrum ea sampole e lumellana le ea referense standard |
Boitsebiso ba HPLC | Nako ea ho boloka sampole ea teko e tsamaisana le ea maemo a referense |
Litaba tsa Metsi (ka KF) | 5.5%~6.5% |
Specific Optical Rotation | +24.0° ho ea ho +30.0° (DMF: MeOH=1:1 C=1%) (ho ntho e anhydrous) |
Masalla a ho Ignition | ≤0.10% |
Lintho Tse Amanang | |
Furoentecavir | ≤0.10% |
Entecavir 1-Epimer | ≤0.10% |
Entecavir 3-Epimer | ≤0.10% |
8-Methyoxy Entecavir | ≤0.10% |
Entecavir 4-Epimer | ≤0.10% |
8-Hydroxy Entecavir | ≤0.10% |
4-Dimethylsilyl Entecavir | ≤0.10% |
Motsoako o amanang le Entecavir A | ≤0.10% |
Tšilafalo efe kapa efe e sa Boleloeng | ≤0.10% |
Litšila ka Kakaretso | ≤0.30% |
Metsoako e setseng | |
Methanol | ≤600ppm |
Dichloromethane | ≤300ppm |
Ethyl Acetate | ≤1000ppm |
Tetrahydrofuran | ≤720ppm |
Toluene | ≤890ppm |
Benzyl Chloride | ≤1000ppm |
Joala ba Benzyl | ≤1000ppm |
Moeli oa Likokoana-hloko | |
Kakaretso ea Lipalo tsa Aerobic | ≤100cfu/g |
Litomoso le hlobo | ≤10cfu/g |
Escherichia Coli | Ha ea Lokela ho Fumaneha |
Litšepe tse boima | ≤10ppm |
Tlhahlobo | 98.0%~102.0% (HPLC; motheong oa anhydrous) |
Boholo ba Karolo | 95% ea likaroloana e lokela ho ba ka hare ho 125um |
Tekanyetso ea Teko | Maemo a Khoebo;United States Pharmacopoeia (USP) Standard |
Tšebeliso | Setlhare sa antiviral se sebelisetsoang ho phekola lefu la Hepatitis B |
Sephutheloana: Botlolo, Aluminium foil bag, Cardboard drum, 25kg/Drum, kapa ho latela tlhoko ea moreki.
Boemo ba polokelo:Boloka ka lijaneng tse koetsoeng sebakeng se phodileng le se omileng;Sireletsa khanya, mongobo le ho hlaseloa ke likokoanyana.
Entecavir Monohydrate (CAS 209216-23-9) ke moriana o thibelang likokoana-hloko o sebelisoang ho phekola tšoaetso ea kokoana-hloko ea Hepatitis B (HBV).Entecavir Monohydrate ke analog ea nucleoside (haholo-holo, analogue ea guanine) e thibelang reverse transcript, DNA replication le transcript ho vira.Ke mofuta o mocha oa lithethefatsi tsa kokoana-hloko ea cyclopentyl acyl guanosine e khahlanong le Hepatitis B e nang le liphello tsa eona tsa meriana tse tšoanang le Entecavir.E sebelisoa ka tleliniki ho phekola batho ba baholo ba sa foleng Hepatitis B moo ho nang le ho ikatisa ha kokoana-hloko e sebetsang, ho eketseha ha serum transaminase ALT kapa liso tse sebetsang tse bontšitsoeng ho tloha histology ea sebete.Entecavir Monohydrate ke inhibitor e matla le e khethollang ea HBV, e nang le EC50 ea 3.75 nM ka seleng ea HepG2.Entecavir ke reverse transcriptase inhibitor.E thibela kokoana-hloko ea Hepatitis B (HBV) ho ikatisa le ho fokotsa bongata ba kokoana-hloko 'meleng.